
zzso zzso 2 zzso decreases gastric and zzso zzso reduces gastric secretions, promotes zzso growth and improves zzso structural and functional adaptation in short zzso syndrome zzso zzso an analogue of zzso has a prolonged zzso and provides zzso effects with zzso subcutaneous injection in patients with zzso This zzso reviews the zzso and clinical data that provide the scientific rationale for the use of zzso in this orphan zzso zzso increases zzso zzso and diminishes the need for zzso support in patients with zzso The adverse event profile is consistent with the underlying disease and the known mechanism of action of zzso Following its positive regulatory review and approval by the European zzso Agency and the zzso Food and Drug Administration in 2012, zzso has moved from the research setting to clinical practice, offering a new treatment paradigm for this burdensome and potentially life-threatening zzso 

